Search results for "Coronavirus"
Clot concerns with adenovirus COVID-19 vaccines, antibody treatment recommendations and data
Based on reports of cerebral venous sinus thrombosis with the Johnson & Johnson (Janssen) COVID-19 vaccine, federal officials recommended a pause in its use, which will be reconsidered on April 23. The NIH updated its recommendations on monoclonal antibody treatments for outpatients.
https://immattersacp.org/weekly/archives/2021/04/20/1.htm
20 Apr 2021
Research on COVID-19 vaccines' duration, reactions, prioritization
Antibodies persisted six months after vaccination, and a graded dosing protocol allowed patients with reactions to a first shot to get a second. Surveyed Americans wanted to prioritize front-line workers and those with chronic conditions for vaccination, and a columnist finds reasons for hope.
https://immattersacp.org/weekly/archives/2021/04/13/1.htm
13 Apr 2021
Postdischarge COVID-19 studies find benefits of home oxygen, risks of PTSD, medical complications
Recent studies focused on patients' status after hospitalization for COVID-19, one finding that outcomes with home oxygen were good, but others noting that post-traumatic stress disorder (PTSD), readmissions, and new diagnoses of medical conditions were common.
https://immattersacp.org/weekly/archives/2021/04/06/2.htm
6 Apr 2021
Primary care's role in COVID-19 vaccination
Patients report that they trust their primary care practitioner the most, because a physician can address their problems in a real, personal way.
https://immattersacp.org/archives/2021/04/primary-cares-role-in-covid-19-vaccination.htm
1 Apr 2021
Answers and even more questions on COVID-19 vaccines
In a fourth forum from ACP and Annals of Internal Medicine, infectious disease experts Carlos del Rio, MD, FACP, Paul Sax, MD, and Deborah Cotton, MD, MPH, FACP, discussed COVID-19 vaccines and their implementation, as well as other aspects of the pandemic response.
https://immattersacp.org/weekly/archives/2021/03/30/2.htm
30 Mar 2021
COVID-19 research looks at aspirin, disparities, long-term outcomes
Recent aspirin use may be associated with improved COVID-19 outcomes, and hospitals had widely differing mortality rates in April 2020. Half of discharged patients reported ongoing symptoms at four months, and most ICU patients showed evidence of impairments at one month, new studies found.
https://immattersacp.org/weekly/archives/2021/03/23/1.htm
23 Mar 2021
Latest COVID-19 research looks at obesity, AKI, nursing home prescribing, symptom checkers
Acute kidney injury (AKI) may have more severe consequences after COVID-19, nursing home residents received risky drugs during the pandemic, and an online symptom checker didn't triage safely, but preprocedural COVID-19 testing showed that vaccinations reduced asymptomatic infections.
https://immattersacp.org/weekly/archives/2021/03/16/1.htm
16 Mar 2021
Latest COVID-19 research details local vaccine reactions, ineffective outpatient treatments
A case series described delayed skin reactions to vaccination, and randomized trials indicated that ivermectin, azithromycin, and convalescent plasma didn't help mildly ill patients. Several studies focused on the increase in alcohol use during the pandemic.
https://immattersacp.org/weekly/archives/2021/03/09/1.htm
9 Mar 2021
New vaccine authorization and data, NIH on antibody treatment and ‘long COVID’
The Johnson & Johnson COVID-19 vaccine got an emergency use authorization, and an Israeli study provided more data on the Pfizer vaccine. The NIH recommended an antibody combo for outpatients and named long-term symptoms as post-acute sequelae of SARS-CoV-2 (PASC).
https://immattersacp.org/weekly/archives/2021/03/02/1.htm
2 Mar 2021
Telehealth options show benefit in treating effects of osteoarthritis
Recent randomized trials in patients with osteoarthritis showed that an app-based program was associated with some reduction in reported pain and that cognitive behavioral therapy by phone improved insomnia symptoms.
https://immattersacp.org/weekly/archives/2021/03/02/4.htm
2 Mar 2021